PBE (PBE) Stock Price & Analysis
PBE (PBE) fell 0.38% to USD 89.59 as of July 25, 2026 at 13:46 UTC, according to Nexqual real-time market data.
PBE last closed at USD 89.94; the session ranged USD 89.59–90.13 on volume of 29,035 shares. Market capitalization is —, with a 52-week range of USD 64.6–94.06 (PCX). Source: Nexqual, July 25, 2026 at 13:46 UTC.
Key Statistics (as of July 25, 2026 at 13:46 UTC)
| Price | USD 89.59 |
|---|---|
| Change | ▼ 0.38% (down) |
| Previous Close | USD 89.94 |
| Open | USD 90.1 |
| Day Range | USD 89.59 – 90.13 |
| 52-Week Range | USD 64.6 – 94.06 |
| Volume | 29,035 shares |
| Market Cap | — |
| Exchange | PCX |
Technical Analysis (PBE)
Nexqual's technical model rates PBE "BUY" based on 4 bullish and 2 bearish signals across 125 daily candles, as of July 25, 2026 at 13:46 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 53.27 (neutral) |
| vs SMA50 | Above (USD 86.32) |
| MACD | 0.96 (positive) |
Financial Health Score (PBE)
Nexqual rates PBE's overall financial health "Mixed" across five dimensions, as of July 25, 2026 at 13:46 UTC.
| Growth | Mixed — No data |
|---|---|
| Profitability | Mixed — No data |
| Balance Sheet | Mixed — No data |
| Cash Flow | Mixed — No data |
| Efficiency | Mixed — No data |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| PJP | Invesco Pharmaceuticals ETF | USD 120.37 | ▲ 1.33% |
| FBT | First Trust Amex Biotech Index | USD 247.39 | ▲ 0.9% |
| PBJ | Invesco Food & Beverage ETF | USD 47.93 | ▼ 1.9% |
| PKB | Invesco Building & Construction | USD 102.41 | ▼ 0.3% |
| BBH | VanEck Biotech ETF | USD 203.57 | ▲ 1.2% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 13:46 UTC. This page is informational and not investment advice.